Effects of indomethacin on the rat small intestinal mucosa: immunohistochemical and biochemical studies using anti-mucin monoclonal antibodies |
| |
Authors: | Tomohisa Iwai Takafumi Ichikawa Yukinobu Goso Tomoaki Ikezawa Yoichi Saegusa Isao Okayasu Katsunori Saigenji Kazuhiko Ishihara |
| |
Affiliation: | (1) Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan;(2) Department of Biochemistry, Kitasato University School of Medicine, Sagamihara, Japan;(3) Department of Regulation Biochemistry, Kitasato University Graduate School of Medical Sciences, 1-15-1, Kitasato, Sagamihara Kanagawa, 228-8555, Japan;(4) Department of Pathology, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara 228-8555, Japan |
| |
Abstract: | Background The luminal surface of the gastrointestinal tract is covered by a viscoelastic gel layer that acts as a protective barrier against the intraluminal environment. Because the situation of the small intestine has not been elucidated to the same degree as other sections, in this study, we investigated the effects of indomethacin on the rat small intestinal mucosa. Methods Male Wistar rats were given indomethacin 10 mg/kg s-c and sacrificed 1, 3, 7, or 14 days later. The small intestine was opened along the anti-mesenteric side, and examined macroscopically. Total mucin content in the small intestinal epithelium was measured and immunoreactivity was examined using anti-mucin monoclonal antibodies HCM31 and PGM34. Results Indomethacin caused punched out and linear ulcers located mostly along the mesenteric margin of the distal jejunum with sparing of the ileum. Histological examination showed sialomucin recognized by HCM31 increased on day 3 especially in the regenerating epithelium around the ulcer edge. Furthermore, the surface mucous gel layer displayed a multilaminated pattern, consisting of non-sulfated sialomucin-rich layers and sulfated mucin-rich layers, where both mucins had the common core protein, MUC2. Biochemical measurements also showed the total mucin content of the jejunum increased transiently and HCM31-positive mucin increased approximately 4 times greater than baseline on day 3, but no marked changes were observed in the ileum, with few ulcers observed. Conclusions Indomethacin administration causes quantitative and qualitative change in jejunal mucin. In particular, sialomucin plays an important role in regenerating epithelium during the healing process following indomethacin-induced mucosal damage. |
| |
Keywords: | NSAIDs Small intestine Monoclonal antibody Sialomucin |
本文献已被 SpringerLink 等数据库收录! |
|